Treasurer of the State of North Carolina’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-18,925
Closed -$626K 1055
2022
Q1
$626K Buy
18,925
+300
+2% +$11.3K ﹤0.01% 980
2021
Q4
$792K Buy
18,625
+120
+0.6% +$5.02K ﹤0.01% 987
2021
Q3
$820K Buy
18,505
+629
+4% +$28.8K ﹤0.01% 989
2021
Q2
$1.02M Sell
17,876
-890
-5% -$62.9K 0.01% 984
2021
Q1
$1.41M Sell
18,766
-50
-0.3% -$4.1K 0.01% 896
2020
Q4
$1.63M Buy
18,816
+50
+0.3% +$3.69K 0.01% 823
2020
Q3
$1.15M Sell
18,766
-20
-0.1% -$1.01K 0.01% 858
2020
Q2
$781K Sell
18,786
-18,209
-49% -$661K 0.01% 937
2020
Q1
$1.06M Buy
36,995
+8,940
+32% +$518K 0.01% 795
2019
Q4
$2.02M Buy
28,055
+130
+0.5% +$16K 0.02% 582
2019
Q3
$3.92M Sell
27,925
-7,920
-22% -$1.32M 0.04% 357
2019
Q2
$6.56M Buy
35,845
+2,367
+7% +$404K 0.04% 382
2019
Q1
$5.33M Buy
33,478
+1,901
+6% +$275K 0.03% 431
2018
Q4
$3.02M Sell
31,577
-10
-0% -$1.14K 0.02% 572
2018
Q3
$4.46M Buy
31,587
+21,387
+210% +$3.3M 0.03% 512
2018
Q2
$1.6M Buy
+10,200
New +$1.6M 0.02% 691

Other funds holding SAGE

Treasurer of the State of North Carolina's SAGE Position: Q2 2022 in Review

Treasurer of the State of North Carolina sold out of Sage Therapeutics (SAGE) in Q2 2022, closing a stake of 18,925 shares — an estimated $626K sold.

Treasurer of the State of North Carolina first reported a position in SAGE in Q2 2018 and held it in 16 quarters. The position peaked at $6.56M in Q2 2019. 210 funds tracked by Wall St. Rank hold SAGE as of Q2 2022.

  • Treasurer of the State of North Carolina reported no remaining Sage Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Treasurer of the State of North Carolina sold 18,925 Sage Therapeutics shares in Q2 2022, an estimated $626K.
  • Treasurer of the State of North Carolina first reported a position in Sage Therapeutics in Q2 2018 and held it in 16 quarters.
  • Treasurer of the State of North Carolina's Sage Therapeutics position peaked at $6.56M in Q2 2019.
  • 210 funds tracked by Wall St. Rank held Sage Therapeutics as of Q2 2022.

Based on Treasurer of the State of North Carolina's 13F filing for Q2 2022, filed 2 Aug 2022.